32
32
Jan 6, 2015
01/15
by
LINKTV
tv
eye 32
favorite 0
quote 0
court in jerusalem handed down three life sentences to hossam qawasme for the killing of eyal yifrach, giladaer, and naftali raenkel. their deaths sparked an escalation in violence that led to this summer's war in gaza. we are in jerusalem and and we hear now on how the families of the boys reacted. >> the father of one of the jewish teenagers that was killed he expressed relief. he said the law should punish the killers with all severity. as we know, hossam qawasme was sentenced to three life sentences today after he was convicted last week for the planning and financing of the kidnapping and killing of three jewish teenagers outside an israeli settlement in the west bank. hossam qawasme was convicted of receiving money from hamas, something around $50,000 that was used to buy weapons and to dairy the victims. as we all know on june 12, three israeli teenagers went missing in the occupied palestinian territories near a settlement. 18 days later, their bodies were found dairy in a land that belonged to hossam qawasme, so this is the situation right now. he was sentenced for three life senten
court in jerusalem handed down three life sentences to hossam qawasme for the killing of eyal yifrach, giladaer, and naftali raenkel. their deaths sparked an escalation in violence that led to this summer's war in gaza. we are in jerusalem and and we hear now on how the families of the boys reacted. >> the father of one of the jewish teenagers that was killed he expressed relief. he said the law should punish the killers with all severity. as we know, hossam qawasme was sentenced to three...
73
73
Jan 15, 2015
01/15
by
CNBC
tv
eye 73
favorite 0
quote 0
everyone said after a couple of days it saw gilad snap back.ave a place where, first of all, biotech has issues. gilad is probably best of breed and it has a valuation that's very ownable right here at 17 times but the stocks, if you look at charts, it's broken to me, and it's starting to get more back. biotech trades only as well as the nasdaq does, as does the overall market so be careful. >> do you agree? do you see biotechs in the market? biotech is not a winning trade. >> i would rather play with ibb and get the four names that these people talk about all the time and mitigate your risk. >> coming up on "mad money," cramer's biotech series. the next generation continues with a triple threat of exclusives. jim discusses what lies ahead for the sector and that's come up on "mad money." don't want to miss that. pops and drops, a drop for yelp. >> gets upgraded and goes down 4%. clearly the broader market didn't help. 40 was the early low in 2014. absolutely has to hold there. >> big pop for taiwan semi? >> i don't like buying stocks straight
everyone said after a couple of days it saw gilad snap back.ave a place where, first of all, biotech has issues. gilad is probably best of breed and it has a valuation that's very ownable right here at 17 times but the stocks, if you look at charts, it's broken to me, and it's starting to get more back. biotech trades only as well as the nasdaq does, as does the overall market so be careful. >> do you agree? do you see biotechs in the market? biotech is not a winning trade. >> i...
43
43
Jan 25, 2015
01/15
by
CSPAN2
tv
eye 43
favorite 0
quote 0
gilad out increasingly bloated health care expenses are.ow untenable the continued growth of health expenditures are your generic drugs appear as an incredibly rare success story in the set of otherwise sales tend to rein in health care cost in health care possible delivery equivalent quality care. but these structures, they begin to become more and more evident and how medicine is practiced and how consumers feel their ability or inability to pursue therapeutic strategies when you're at the pharmacy. i think one way in which we see it increasingly is moving beyond the structure of generic substitution where i will pay for you to have this molecule be put in your body but only at the generic price. so i will reimburse the generic version but not the brain. you can buy the brand but you won't pay for. therapeutics structure, and ensure will say sure you have high cholesterol and you should be on a step in, but their eight in the american market right now and i am not going to reimburse -- were not going to reimburse you to take this most exp
gilad out increasingly bloated health care expenses are.ow untenable the continued growth of health expenditures are your generic drugs appear as an incredibly rare success story in the set of otherwise sales tend to rein in health care cost in health care possible delivery equivalent quality care. but these structures, they begin to become more and more evident and how medicine is practiced and how consumers feel their ability or inability to pursue therapeutic strategies when you're at the...
265
265
Jan 29, 2015
01/15
by
CNNW
tv
eye 265
favorite 0
quote 1
engaging in asymmetrical trades literally hundreds the last exchange was well over 1,000, to redeem a giladt hamas had captured. this is a long war. and there's no way it's going to come to an end. there are battles, you got to pick your fight. if there are literally exchange where you can benefit and profit even on a moral, humanitarian or in a sense that the jordanians are dealing with, terrible pliltolitical problem. rising opposition. they want this guy back he's the member of a prominent jordanian family and tribe. critical to the support of the king. so the realities, people do negotiate. if in fact it's in their self-interest. we did it with bowe bergdahl despite the administration's efforts to deny these are similar exchange. >> it sets up a perceived hypocrisy that has the u.s. in trouble, not just against those who would be its enemy, but also those who were its allies it seems to be double-speak. to you draw conclusions from the fact that the terrorist group has changed its perspective? usually it just you know wantonly kills people and puts out videos about it. this time they ke
engaging in asymmetrical trades literally hundreds the last exchange was well over 1,000, to redeem a giladt hamas had captured. this is a long war. and there's no way it's going to come to an end. there are battles, you got to pick your fight. if there are literally exchange where you can benefit and profit even on a moral, humanitarian or in a sense that the jordanians are dealing with, terrible pliltolitical problem. rising opposition. they want this guy back he's the member of a prominent...